Skip to main content
Equibles

FMR LLC

Position in CADL — Candel Therapeutics, Inc.

CIK 315066 BOSTON, MA
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$113,202,510
+$59,366,128 QoQ
Shares Held
10,990,535
+0.0% QoQ
Ownership
14.4%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 138 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. CADL ranks #93 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in CADL

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $113,202,510 10,990,535
2026-03-31 $53,836,382 10,987,017
2025-12-31 $46,523,788 8,234,299
2025-09-30 $41,990,263 8,233,385
2025-06-30 $41,661,180 8,233,435
2025-03-31 $40,032,035 7,085,316
2024-12-31 $34,056,839 3,923,599
2024-09-30 $45,550 6,573
2023-12-31 $438,624 298,384
2023-09-30 $403,933 439,058
2023-06-30 $570,221 452,557
2023-03-31 $827,761 613,157
2022-12-31 $1,320,296 737,596
2022-09-30 $2,824,112 899,399
2022-06-30 $2,914,052 899,399
2022-03-31 $10,038,630 1,972,226
2021-12-31 $17,695,424 2,262,842
2021-09-30 $27,100,000 2,500,000